States step up against “gas station heroin” — Connecticut bans tianeptine as medical experts warn of deadly risks
Tianeptine, often called “gas station heroin,” is an unapproved opioid-like substance widely sold in convenience stores, vape shops and online. Health experts warn it can cause addiction, respiratory depression and fatal overdoses; Connecticut’s sale ban begins this week.
- States and enforcement: At least 14 states now restrict or schedule tianeptine; Connecticut’s ban on sale and use takes effect this week — see FDA.
- Potency and risk: Recreational doses can activate mu‑opioid receptors, produce euphoria, be more potent than morphine, and cause fatal respiratory depression — noted by Mayo Clinic.
- Availability and masking: Products (e.g., Tianaa, ZaZa, Neptune’s Fix, Pegasus, TD Red) are sold in candy‑like forms and marketed as supplements — see VCU Health and FDA.
- Detection and treatment: Standard drug screens often miss tianeptine; clinicians should report cases to poison centers such as those referenced in the NJ Health Alert.
WASHINGTON (Times Media Service) –
Background and pharmacology
Tianeptine is a tricyclic compound developed decades ago as an antidepressant and remains prescribed in some countries at low doses (roughly 12–36 mg/day) for depression, anxiety or irritable bowel syndrome. The drug has never been approved for medical use in the United States; see the FDA and the Mayo Clinic.
At low, prescribed doses tianeptine primarily affects serotonin pathways. At much higher doses — sometimes hundreds of times therapeutic levels — it activates mu‑opioid receptors and produces strong euphoria and opioid‑like respiratory depression. Reported recreational use has reached doses far beyond prescription ranges; see a summary at NCBI summary and legislative analysis such as the Texas bill analysis.
Health risks and adverse effects
Health officials warn misuse can produce a wide clinical spectrum. Early symptoms include agitation, confusion, sweating, nausea and vomiting. Serious signs include severe sedation, slowed breathing, low oxygen levels, seizures, coma and death. Cardiac effects such as tachycardia, bradycardia or arrhythmias have also been reported; see FDA and Mayo Clinic.
Mixing tianeptine with alcohol, prescription opioids, benzodiazepines or synthetic cannabinoids increases harm; clusters with mixed products (including Neptune’s Fix) have produced deaths and critical illnesses — documented in local alerts such as the NJ Health Alert. Withdrawal can mirror opioid withdrawal — intense cravings, sweating, piloerection, diarrhea and myalgias — and may require supervised medical care. Standard toxicology panels often fail to detect tianeptine, delaying diagnosis and care.
Availability and marketing
Investigators report these products are easy to find at convenience stores, gas stations, vape shops and online. Packaging and product names are crafted to attract attention; many come in candy‑like flavors that can appeal to teens and young adults. Labels frequently claim the items are dietary supplements or nootropics, making false promises about mood, pain relief, energy or sexual performance — a core concern highlighted by the FDA and VCU Health.
U.S. poison centers have recorded rising exposures over the last two decades, with recent regional clusters requiring ICU care; Virginia’s poison center noted a marked increase in 2024 and roughly one‑third of serious cases needed intensive care, according to reporting summarized by local centers and hospitals.
Regulatory actions at the state and federal level
States have moved where federal approval and national scheduling are lacking. At least 14 states now classify tianeptine as a Schedule I controlled substance, making possession, sale or manufacture illegal in those jurisdictions. Connecticut recently added tianeptine to its schedule (effective this week), alongside kratom, with Lt. Gov. Susan Bysiewicz citing the need to combat addiction and protect young people and those with substance‑use disorder; see FDA.
Other states such as Virginia and New Jersey took action following local clusters of illness and death. Lawmakers in Texas and elsewhere have debated bills that address tianeptine alongside kratom; see the Texas bill analysis. At the federal level, lawmakers have reintroduced measures to bar marketing that falsely labels these products as dietary supplements — see the Pallone press release.
FDA messaging and expert warnings
FDA officials have repeatedly warned consumers about tianeptine risks in consumer products. In a recent letter, FDA leadership urged the public to recognize the growing health risk, particularly for young people. The agency underscores that tianeptine is not FDA‑approved and is being falsely marketed as a supplement; see FDA.
“At low doses tianeptine affects serotonin pathways, but at high doses it stimulates mu‑opioid receptors and can produce respiratory failure similar to heroin,” said Dr. Robert Schwaner, quoted in reporting summarized by user-provided research.
Implications for Los Angeles, California
As states tighten controls and public health warnings intensify, Los Angeles‑area retailers, clinicians, public health officials and law enforcement may see direct impacts. Below are local implications and recommended actions.
Economic and retail impact
Convenience stores, vape shops and online retailers in Los Angeles could alter product offerings to avoid liability and enforcement scrutiny. Retailers that sold items labeled Tianaa, Neptune’s Fix, Pegasus or TD Red may pull inventory and review supplier practices. Small businesses should audit stock and supplier claims to avoid unknowingly carrying illegal or dangerous items; regulatory context is summarized by the FDA.
Public health and medical services
Los Angeles hospitals and emergency departments should remain vigilant for tianeptine toxicity and withdrawal. Because routine drug tests often miss tianeptine, clinicians and toxicologists must consider it for unexplained respiratory depression, severe sedation or opioid‑like withdrawal. Public health authorities may expand training for first responders and reporting to state poison centers, following examples like the NJ Health Alert and regional advisories.
Vulnerable populations
Youth and people with substance‑use disorders are especially at risk. Candy‑like flavors, online marketing and street names increase youth appeal. Outreach to schools, youth centers and community organizations is crucial, and treatment programs should prepare to manage tianeptine dependence and withdrawal alongside opioid use disorder; see patient guidance from Mayo Clinic.
Law enforcement and policy
California lawmakers and Los Angeles officials may face pressure to consider local controls. Options include scheduling, targeted vendor enforcement, education campaigns and coordination with federal agencies to trace supply chains. National legislative efforts to curb misleading marketing are outlined in the Pallone press release.
Resources and what to do if exposure is suspected
If tianeptine exposure or overdose is suspected, call local emergency services immediately or Poison Control at 1‑800‑222‑1222 (national number used by state health officials). The SAMHSA national helpline can help people find treatment for substance‑use issues. Clinicians should report cases to state poison centers and public health authorities so officials can track trends and clusters; see the NJ Health Alert for reporting guidance.
Reporting and continued coverage
As more states add tianeptine to controlled substance lists and federal lawmakers press for limits on misleading marketing, consumers and clinicians in Los Angeles and nationwide are urged to treat products labeled as dietary supplements with caution. Ongoing reporting, poison‑center surveillance and regulatory coordination will be key to tracking the spread of these unregulated products and protecting public health; see ongoing statements from the FDA and public education from VCU Health.
Sources: FDA; Mayo Clinic; VCU Health; NJ Health Alert; NCBI summary; Texas bill analysis; Pallone press release; SAMHSA.
